Parilman & Associates – Chemotherapy Injury Attorneys
Taxotere is a very commonly used chemotherapy for the treatment of breast cancer and other cancers. Recently the makers of Taxotere have come under scrutiny for not properly warning patients about lasting, permanent side effects resulting in legal actions against them. With the number of women that receive this treatment, the number of potential cases are expected to increase greatly.
Taxotere (docetaxel) is an intravenous chemotherapy used for the treatment of cancer, most commonly breast cancer, since its 1996 FDA approval. Taxotere is sold by Sanofi-Adventis and is used to treat up to 75 percent of all breast cancer cases in the United States. While Taxotere has shown to extend the survival of breast cancer patients more so than other drugs, the drug has also been found to have unsettling, lasting side effects in the form of permanent hair loss.
Taxotere Side Effects:
While hair loss is a common side effect of chemotherapy drugs, Taxotere’s side effects are permanent and even disfiguring. Side effects include:
- Hair loss lasting longer than 3-6 months following the end of treatment
- Alopecia (permanent hair loss)
As of 2016, women have begun filing lawsuits against the makers of Taxotere for failing to warn patients of permanent side effects following use. As of now, cases are not being lumped into a class action suit meaning that each patient will need to file individually against the manufacturer of the chemotherapy drug. Contact Parilman Law for more information if you believe you have experienced the above side effects after receiving Taxotere.